clindamycin has been researched along with Cancrum Oris in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enwonwu, CO; Falkler, WA; Idigbe, EO | 1 |
Iwai, N; Kato, H | 1 |
2 other study(ies) available for clindamycin and Cancrum Oris
Article | Year |
---|---|
Isolation of Fusobacterium necrophorum from cancrum oris (noma).
Topics: Adolescent; Anti-Bacterial Agents; Bacteroidaceae Infections; Child; Child, Preschool; Clindamycin; Culture Media; Drug Resistance, Microbial; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Noma; Nutrition Disorders; Penicillins; Prevotella intermedia; Tetracycline | 1999 |
[Clinical study of clindamycin-2-palmitate treatment in pediatric infections (author's transl)].
Topics: Abscess; Child; Clindamycin; Drug Evaluation; Drug Resistance, Microbial; Empyema; Female; Humans; Infant, Newborn; Noma; Palmitic Acids; Pneumonia; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Tonsillitis | 1973 |